medigraphic.com
ISSN 1405-1710 (Print)

2017, Number 1

<< Back Next >>

Rev Cent Dermatol Pascua 2017; 26 (1)

Extragenital lichen sclerosus. Communication of a case

Rodríguez-Acar MC, Neri-Carmona M, Elizondo-Rodríguez A, Álvarez-Hernández MD, González HV

Language: Spanish
References: 20
Page: 15-19
PDF size: 439.47 Kb.


ABSTRACT

Scleroatrophic lichen is a chronic inflammatory disease of the skin of unknown etiology, with a special predilection for the female genital area. We report the case of a 36-year-old female patient who began her illness with the appearance of hypopigmented macules that over the years converged to form scleroatrophic plaques. We communicate this case of extragenital scleroatrophic lichen because of the low frequency of its presentation, due to the location of the lesions.


REFERENCES

  1. Guerra A. Liquen escleroso. Actas Dermosifiliogr. 2003; 94: 633-641.

  2. Sandoval MJ, Quenardelle AS, Slimel M, López CC, Giménez MF. Liquen escleroso y atrófico extragenital. Arch Argent Dermatol. 2011; 61: 251-254.

  3. Fistarol SK, Itin PH. Diagnosis and treatment of lichen sclerosus: an update. Am J Clin Dermatol. 2013; 14: 27-47.

  4. Alfaro SA, Casados VR. Liquen escleroso y atrófico vulvar. Dermatol Rev Mex. 2013; 57: 394-397.

  5. Monsálvez V, Rivera R, Vanaclocha F. Liquen escleroso. Actas Dermosifiliogr. 2010; 101: 31-38.

  6. Clifton MM, Garner IB, Kohler S, Smoller BR. Immunohistochemical evaluation of androgen receptors in genital and extragenital lichen sclerosus: evidence for loss of androgen receptors in lesional epidermis. J Am Acad Dermatol. 1999; 41: 43-46.

  7. Sideri M, Origoni M, Spinaci L, Ferrari A. Topical testosterone in the treatment of vulvar lichen sclerosus. Int J Gynaecol Obstet. 1994; 46: 53-56.

  8. Moreira PM, Díaz AJ, Moredo RE. Liquen escleroso y atrófico extragenital. Rev Cubana Med. 2003; 42: 36-39.

  9. Moreno M, Torrelo A, Mediero IG, Zambrano A. Liquen escleroso y atrófico extragenital en niños. Actas Dermosifiliogr. 2000; 91: 385-389.

  10. Scauder MB, Linzon-Smith J, Beecker J. Extragenital bullous lichen sclerosus. J Am Acad Dermatol. 2014; 71: 981-984.

  11. Guzmán L, Santana C. Coexistencia de liquen escleroso y atrófico y morfea. Revista Dominicana de Dermatología. 2012; 39: 31.

  12. Alfaro SA, Casados VR. Liquen escleroso y atrófico vulvar. Dermatol Rev Mex. 2013; 57: 394-397.

  13. Gutiérrez-Pascual M, Vicente-Martín FJ, López-Estebaranz JL. Liquen escleroso y carcinoma escamoso. Actas Dermosifiliogr. 2012; 103: 21-28.

  14. Lever W. Histopatología de la piel. Séptima ed. Argentina: Ed. Interamericana; 1991. pp. 294-298.

  15. Larre BA, Tiodorovic-Zivkovic D, Lallas A, Moscarella E, Gurgitano S, Capurro M et al. Clinical, dermoscopic and histopathologic features of genital and extragenital lichen sclerosus. J Eur Acad Dermatol Venereol. 2013; 27: 1433-1439.

  16. Neill SM, Lewis FM, Tatnall FM, Cox NH; British Association of Dermatologists. British Association of Dermatologists’ guidelines for the management of lichen sclerosus 2010. Br J Dermatol. 2010; 163: 672-682.

  17. Kreuter A, Tigges C, Gaifullina R, Kirschke J, Altmeyer P, Gambichler T. Pulsed high-dose corticosteroids combined with low-dose methotrexate treatment in patients with refractory generalized extragenital lichen sclerosus. Arch Dermatol. 2009; 145: 1303-1308.

  18. Lin AN. Innovative use of topical calcineurin inhibitors. Dermatol Clin. 2010; 28: 535-545.

  19. Bousema MT, Romppanen U, Geiger JM, Baudin M, Vähä-Eskeli K, Vartiainen J et al. Acitretin in the treatment of severe lichen sclerosus et atrophicus of the vulva: a double-blind, placebo-controlled study. J Am Acad Dermatol. 1994; 30: 225-231.

  20. Bulbul Baskan E, Turan H, Tunali S, Toker SC, Saricaoglu H. Open-label trial of cyclosporine for vulvar lichen sclerosus. J Am Acad Dermatol. 2007; 57: 276-278.




2020     |     www.medigraphic.com